PUBLICATION
Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression
- Authors
- Mattis, K.K., Krentz, N.A.J., Metzendorf, C., Abaitua, F., Spigelman, A.F., Sun, H., Ikle, J.M., Thaman, S., Rottner, A.K., Bautista, A., Mazzaferro, E., Perez-Alcantara, M., Manning Fox, J.E., Torres, J.M., Wesolowska-Andersen, A., Yu, G.Z., Mahajan, A., Larsson, A., MacDonald, P.E., Davies, B., den Hoed, M., Gloyn, A.L.
- ID
- ZDB-PUB-230113-5
- Date
- 2023
- Source
- Diabetologia 66(4): 674-694 (Journal)
- Registered Authors
- Ikle, Jen
- Keywords
- Beta cell, CRISPR/Cas9, Diabetes, Differentiation, Human genetics, Pancreatic islet, RREB1, Stem cell, Transcription factor, Zebrafish
- MeSH Terms
-
- Animals
- DNA-Binding Proteins/metabolism
- Diabetes Mellitus, Type 2*/metabolism
- Gene Expression
- Glucose/metabolism
- Humans
- Induced Pluripotent Stem Cells*/metabolism
- Insulin/metabolism
- Insulin-Secreting Cells*/metabolism
- Transcription Factors/genetics
- Zebrafish/genetics
- PubMed
- 36633628 Full text @ Diabetologia
Citation
Mattis, K.K., Krentz, N.A.J., Metzendorf, C., Abaitua, F., Spigelman, A.F., Sun, H., Ikle, J.M., Thaman, S., Rottner, A.K., Bautista, A., Mazzaferro, E., Perez-Alcantara, M., Manning Fox, J.E., Torres, J.M., Wesolowska-Andersen, A., Yu, G.Z., Mahajan, A., Larsson, A., MacDonald, P.E., Davies, B., den Hoed, M., Gloyn, A.L. (2023) Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression. Diabetologia. 66(4):674-694.
Abstract
Aims/hypothesis Genome-wide studies have uncovered multiple independent signals at the RREB1 locus associated with altered type 2 diabetes risk and related glycaemic traits. However, little is known about the function of the zinc finger transcription factor Ras-responsive element binding protein 1 (RREB1) in glucose homeostasis or how changes in its expression and/or function influence diabetes risk.
Methods A zebrafish model lacking rreb1a and rreb1b was used to study the effect of RREB1 loss in vivo. Using transcriptomic and cellular phenotyping of a human beta cell model (EndoC-βH1) and human induced pluripotent stem cell (hiPSC)-derived beta-like cells, we investigated how loss of RREB1 expression and activity affects pancreatic endocrine cell development and function. Ex vivo measurements of human islet function were performed in donor islets from carriers of RREB1 type 2 diabetes risk alleles.
Results CRISPR/Cas9-mediated loss of rreb1a and rreb1b function in zebrafish supports an in vivo role for the transcription factor in beta cell mass, beta cell insulin expression and glucose levels. Loss of RREB1 also reduced insulin gene expression and cellular insulin content in EndoC-βH1 cells and impaired insulin secretion under prolonged stimulation. Transcriptomic analysis of RREB1 knockdown and knockout EndoC-βH1 cells supports RREB1 as a novel regulator of genes involved in insulin secretion. In vitro differentiation of RREB1KO/KO hiPSCs revealed dysregulation of pro-endocrine cell genes, including RFX family members, suggesting that RREB1 also regulates genes involved in endocrine cell development. Human donor islets from carriers of type 2 diabetes risk alleles in RREB1 have altered glucose-stimulated insulin secretion ex vivo, consistent with a role for RREB1 in regulating islet cell function.
Conclusions/interpretation Together, our results indicate that RREB1 regulates beta cell function by transcriptionally regulating the expression of genes involved in beta cell development and function.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping